Exam 2 Flashcards

1
Q

Indicate whether most enteric viruses are enveloped or not, and describe why this is important. 


A
  • Most are not enveloped

- Helps stability in environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Be able to outline the common pathogenesis for enteric viral infections as it relates to the intestinal mucosa architecture, segment of gut affected and clinical signs.

A
  • Villous blunting (atrophy) = malabsorption & osmotic D
  • Cl- secretion = water drawn to lumen = secretory D
  • Inflammation = vascular permeability = loose tight junctions = exudative D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List the common features of enteric viruses with regards to transmission, incubation period, age of most susceptibility, host specificity.

A
  • Fecal-oral transmission
  • Short incubation period
  • Severe disease in young animals
  • Most are host species specific
  • Most cause localized, transient infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe which factors influence the severity of disease for enteric viral infections

A
  • Dose of virus
  • Host nutrition / health
  • Underlying / concurrent infections
  • Maternal Ab or vaccination
  • Genetics of virus & host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain why it is important to provide non-oral fluid replacement in cases of rotavirus/coronavirus enteritis.

A

These viruses cause villus atrophy/blunting which results in decreased ability to absorb water and nutrients. If you give oral fluids, those fluids will not be absorbed in the intestine or at all.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rotavirus: who does is affect? diagnosis? Pathogenesis? Treatment? Prevention?

A
  • Species specific for cows, pigs, goats, horses, dogs, & humans
  • non-enveloped & stable
  • Results in acute white/yellow mucoid D (no blood) in baby animals (scours)
  • Lasts 8-10 days
  • Diagnosis: PCR/ELISA
  • Pathogenesis: infects mature epithelial cells at villous tips in small intestine -> enterocyte damage = malabsorptive D & NSP4 enterotoxin -> secrete Cl- = secretory D
  • Treatment: self-limiting, provide fluids & limit food
  • Prevention: Vx dam prior to birthing, manage quality of housing, stress, nutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Coronavirus: enveloped or not? Pathogenesis?

A
  • Enveloped but relatively stable
  • Pathogenesis: infects mature epithelial cells at villous tips in small intestine -> enterocyte damage = malabsorptive D & enterotoxin -> secrete Cl- = secretory D
  • Can also go to colon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 Coronaviruses in Pigs

A

Transmissible Gastroenteritis (TGE) in pigs

  • Highly contagious, localized enteric infection 

  • Incubation period 18-72 hrs 
- Naïve herds (never exposed to virus) 

  • All ages affected, mortality in young
  • profuse diarrhea and some vomiting
  • starts when maternal Abs waning
  • Pathogenesis: same as any coronavirus

Porcine epidemic diarrhea virus (PED)

  • Pathogenesis: same as any coronavirus
  • New to US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bovine Coronavirus 3 clinical presentations

A
  • Calf diarrhea (similar to endemic TGE)
  • Winter dysentery of adult dairy cattle: Sporadic acute enteric disease, diarrhea with blood, low mortality
  • Respiratory disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Equine Coronavirus; who does it affect? shedding? clinical signs? diagnostics? pathogenesis? treatment?

A
  • usually affects adult horses
  • Incubation period 48-72 hrs with peak viral shedding 3-4 days AFTER clinical signs
  • Shedding is usually for 3-25 days, but up to 99 days
  • Clinical signs: anorexia, lethargy, fever, mild colic, maybe Ds, neuro symptoms
  • Diagnostics: CBC/Chem shows leukopenia & hypoalbuminemia
  • Pathogenesis: Overgrowth of urease-producing bacteria or increase in ammonia absorption through disrupted small intestinal mucosa = hyperammonemia & associated encephalopathy
  • Death unusual
  • Treatment: fluid therapy and NSAIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Feline Enteric Corona Virus

A
  • Common
  • Subclinical or mild D
  • Can mutate to feline infectious peritonitis (FIP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Feline infectious Peritonitis (FIP) clinical signs, prevention, wet form, dry form

A
  • Mutation from FECV or FIPV
  • Usually < 1yo from multi-cat household

Clinical signs:
- fever, weight loss, anorexia

Prevention
- FIP vx is not effective

Effusive or wet form of FIP

  • 75% of cases
  • Inflammation of the serosal surfaces of the abdomen and/or thorax
  • Accumulation of proteinaceous fluid in the body cavities
  • Often leads to apparent abdominal distention, respiratory distress (due to pleural effusion)

Non effusive or dry FIP

  • Pyogranulomatous inflammation following vessels of parenchymal organs 

  • kidneys, lymph nodes, liver, pancreas, CNS, uveal tract of the eye 

  • Effusion absent or minimal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the importance in an individual cat’s immune response (humeral and CMI) in the development of disease with FIP infection.

A
  • FIPV infection -> strong CMI (cell mediated) -> no disease
  • FIPV infection -> strong Ab & weak CMI -> wet FIP
  • FIPV infection -> weak Ab & moderate CMI -> dry FIP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indicate the pathological cause for body cavity effusion in feline infectious peritonitis virus infection.

A

Kidneys and other organs are affected by pyogranulomatous vasculitis -> increases intravascular pressure -> leakage of high protein fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the utilities of serology and PCR as diagnostic tests for feline infectious peritonitis virus infection and indicate the gold-standard for FIP diagnosis. Explain why it is difficult to diagnose FIP in a living patient, and what findings support a diagnosis.

A
  • no single antemortem test available to diagnose FIP so combine serolgy & symptoms to presume diagnosis

definitive diagnosis:
- combine biopsy of grnauloma & immunohistochemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Parvovirus Pathogenesis & Clinical Findings

A

Pathogenesis
- Oronasal exposure -> entry & replication in GI lymph tissue -> moves to systemic lymph tissue -> systemic viremia -> Replication and necrosis of intestinal crypt epithelium, bone marrow, lymphoid tissue

Clinical Findings
- Fever, bloody osmotic D, & loss of immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain how incorrect timing/frequency of parvovirus vaccination can lead to a lack of protection.

A
  • If given too early, maternal Ab block pup from making own Abs
  • If given too late, no maternal Ab and no own Ab = high exposure
  • Should vaccinate multiple times while young to hopefully land in perfect window
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain how mitotically active cells are important in the viral lifecycle and clinical pathogenesis of parvoviral enteritis

A
  • Small DNA virus that does not carry DNA polymerase genes
  • Uses cellular DNA polymerase
  • Needs mitotically active cells to have plenty polymerase
  • Crypt epithelium, lymph tissue, cerebellum (cat), heart (dog)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Parvovirus Treatment, Diagnosis, Prevention

A

Treatment

  • Aggressive supportive care to counteract diarrhea & immunosuppression
  • Antibiotics for secondary bacterial infections

Diagnosis

  • Rapid antigen ELISA detects virus in feces (retest if negative because intermittent shedding)
  • If fatal histologic lesions and intranuclear inclusions are diagnostic

Prevention

  • Inactivated and attenuated (modified live) vaccines are available and effective
  • Fecal shedding from vaccinated (MLVs) dogs can immunize other dogs
  • DO NOT vaccinate pregnant or very young animals with MLV - potential for myocardial infections and cerebellar disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Parvoviral Myocardial Disease in Dogs

A
  • Was common when disease first emerged
  • pups born w/out maternal Ab and susceptible to infection at a very early age
  • Pups infected while myocardium still developing and susceptible to infection = acute heart failure and sudden death
  • now pups usually not susceptible at young age or infected when older and myocardium no longer in active development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Parvoviral Cerebellar Disease in Cats

A
  • Infection during late gestation/early neonatal period
  • Virus has tropism for cells in the cerebellum
  • cerebellar hypoplasia most commonly
  • Ataxia, incoordination, tremors, broad-based stance with hypermetric movements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Canine Adenovirus

A
  • Non-enveloped, stable DNA virus 

  • Seldom seen anymore due to highly effective vaccination 

  • <1yrs or unvaccinated dogs
  • Clinically-asymptomatic to fatal
  • Highly contagious virus that can cause clinical disease in bears, fox, coyotes, wolves, raccoons, skunk, mink and ferrets
  • Makes intranuclear occluisons in hepatocytes & endothelial cells -> fatal hepatitis, hepatic necrosis and hemorrhagic disease
  • Use canine adenovirus 2 to avoid “blue eye”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Identify the major source of parvovirus for susceptible animals and major ways to control transmission.

A

Transiently infected animals & environment (survives well outside of host)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

2 clinical outcomes of alpha herpesvirus & transmission

A

Clinical outcomes

i. Active replication
ii. Latency/reactivation

Transmission

i. Close contact, Short-distance aerosol
ii. Between moist epithelial surfaces
iii. Closely confined populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Explain the differences in pathogenesis and associated clinical signs between EHV-1 and EHV-4. Explain how EHV-1 can causes systemic disease, how neurologic disease can develop in EHV-1, and which cells are infected

A

EHV – 1
i. Starts in resp. epithelium -> infection of lymphocytes -> affects other organs systems thru infection of endothelium

EHV – 4

i. Localized upper respiratory infection
ii. Regional lymphadenopathy, nasal discharge, coughing

iii. Subclinical or mild to moderate,
iv. self-limiting = full recovery

v. low resp. infection rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Explain how herpesviruses are maintained in the population.

A

a. Life-long infection (carriers)

b. Viral replication and shedding occurs w/ or w/out clinical Dz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Equine Herpes Virus Persistence

A

a. Both EHV-1 and 4 target neuronal cells in sensory ganglia innervating nasopharyngeal mucosa
b. EHV-1 is lymphotrophic (latency in T cells)
c. Reactivation with lytic infection occurs in adult horses with or without clinical signs
d. seen with “stress” – e.g. pregnancy, shipping, racing, training, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

EHV Systemic Dz

A

a. Spread outside of resp. associated w/ lymphocyte tropism
b. Virus accesses lymphocytes -> Replication in regional lymph nodes -> Cell-associated viremia -> Virus disseminates to endothelium in target tissues 
-> causes abortion in uterus & neuro dz in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Abortion due to EHV-1

A

a. Frequently occurs without respiratory or CNS disease
b. Uterine vasculitis necessary and sufficient for abortion
c. Fetus can be virus (-) but usually also crosses the placenta and infects the fetus, causing disseminated disease in the fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Equine Herpes Myeloencephalitis: clinical signs, key lesions, diagnosis

A

Clinical signs:

i. mild ataxia to paresis 

ii. incoordination, gait abnormalities
iii. inability to rise from the sitting position 

iv. may have paralysis and recumbency 


Key lesions

i. vasculitis and ischemia
ii. neurons are not infected

Diagnosis

i. History and clinical signs very important!
ii. EHV-1 Serology (acute and convalescent)
iii. EHV-1 PCR
 (Blood PBMCs or nasal swab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Vaccine for Equine Herpes

A

i. Widely used

ii. EHV-1 and EHV-4 are cross-protective
iii. reduce severity of respiratory and abortive disease and/or prevent outbreaks of disease
iv. Frequent revaccination is needed 

v. Maternal antibodies interfere with protection of young horses 

vi. Vaccines not protective against neurologic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Bovine Alpha herpesvirus

A

Infectious Bovine Rhinotracheitis (IBR)

BHV-1

  • major cause of resp dz and abortion
  • does not infect endothelium
  • abortion due to actual infection of the fetus in all cases

BHV-5
i. CNS disease affects brain, infects neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Feline alpha herpes virus 1; basics, how long is shedding, symptoms

A

o most important pathogen of upper respiratory disease in cats
o localized in upper respiratory tract
o Secondary bacterial infections
o Active shedding usually lags behind stressful event – can transmit virus for 3 weeks post event 

o Viremia – very rare; occurs in hypothermic kittens

Symptoms
• conjunctivitis, ulcerative keratitis/dermatitis/ stomatitis, rhinitis, sometime abortion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Feline Calcivirus; basics, symptoms, hypervirulent strain

A

o Upper respiratory
o Small, non-enveloped, RNA virus
o Shed in ocular, nasal, oral secretions (think Calici if oral issues)
o Common persistent infections
o Virus persists in tonsils and other oropharyngeal tissues

Symptoms
• fever, sneezing, coughing, nasal and ocular discharge
• may have disease in lungs or joints

Hypervirulent strain
• infects endothelial cells = hemorrhagic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Canine Alphaherpesvirus

A

o In utero infection = abortion/fetal loss

o Neonatal infection = fatal multisystemic hemorrhage and necrosis
o Adult infection = typically not pathogenic but can cause mild respiratory disease (rhinotracheitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Macacine Herpesvirus

A

o Macaques
o Oral and gingival ulcers
o High seroprevalence in captive and wild cohorts

Fatal cross-species transmission

• humans can get fatal encephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Betaherpes virus Family Basics

A

o Slow replication and “cytomegaly” 

o Latency - established primarily in secretory epithelium 

o Ubiquitous - frequently encountered when searching for causative agents
o generally NOT true cause of disease 

o Disease, if any, is generally limited to immunocompromised hosts 

o Example of disease causing: Elephantid herpesvirus 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Elephantid herpesvirus 1

A
  • Betaherpes virus
  • Targets endothelial cells -> lethal hemorrhagic disease
  • Seen in young Asian elephants
  • Responds to antiviral therapy if administered rapidly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Gammaherpes virus Family basics

A

o Lymphotropic herpesviruses
o Often non-productive, non-lytic infections
o express various viral genes that activate cells, interfere with cell cycle, modulate the host immune response
o most are non-pathogenic in immunocompetent natural hosts
o if disease = lymphoid neoplasia and/or lymphoproliferative disease
o Example of disease caused: Malignant Catarrhal fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Malignant Catarrhal fever: basics, clinical signs

A
  • Gammaherpesvirus
  • Infection of non-adapted host
  • Caused in cows by Ovine Herpesvirus 2
  • Fatal systemic dz
  • Cannot pass from cow to cow (dead end hosts)

Clinical signs
• Epithelial erosion of upper respiratory and intestinal tracts, 
eyes, lymph nodes



How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Malignant Catarrhal fever: pathogenesis

A

Pathogenesis
• OHV-2 infects sheep respiratory tract ->
• viremia ->
• infection of lymphocytes ->
• difficult to detect virus replication ->
• no clinical disease ->
• passed to cattle thru nasal secretions ->
• Proliferation of perivascular lymphocytes ->
• Necrotizing vasculitis systemically ->
• Ischemic necrosis
• Mucosal erosion & ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Malignant Catarrhal fever: Diagnosis, Transmission, & Control

A

Diagnosis
• Clinical signs, exposure to carriers, vasculitis on histopathology, PCR detection of virus (lymphoid tissues) 

• Serology - limited value since some animals may be subclinically infected
• Important differentials includes exotic diseases 


Transmission
• Close Distance
• Cool moist environment
• Sheep shed OVH-2 most intensely at 6-8 months old

Control
• There is no vaccine available 

• Management practices - separate sheep from cattle, bison, deer 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Orthomyxoviridae

A

o Influenza
o Localized respiratory tract infections (except birds)
o Enveloped virus
o Single stranded (-) RNA genome
o Segmented genome
o 3 main types: A, B, and C (mainly influenza A)

44
Q

Influenza A: key envelope proteins, host range, reservoir

A

Key envelope proteins:
• Hemagglutin or HA: critical for viral entry
• Neuraminidase NA: critical for viral exit
• divided into subtypes based on antigens present on HA & NA

Host range
• Dictated by presence of sialic acid which is carb receptor

Resevoir 
•	Waterfowl
•	Harbor all H & N types
•	Subclinical persistent infections
•	Ag shift from bird to human occurs in pigs
45
Q

Hemagglutin (HA) Vs Neuraminidase (NA)

A

Hemagglutin (HA)
• primary binding to sialic acid – dictates host susceptibility
• must be cleaved by extracellular host proteases for fusion protein to be exposed
• Presence of host proteases partially defines tissue tropism
• 3 HA monomers = trimer = viral ligand
• homotrimer binds sialic acid on target cells -> Endocytosis -> Drop in pH w/in vesicle -> HA conformational change -> Fusion & RNA release

Neuraminidase (NA)
• Cleaves scialic acid for release

46
Q

How does antigenic variation occur in flu

A
  • HA & NA carry neutralizing Ag
  • Changes to Ag allow evasion of immune

Ag drift
o Minor change
o Point mutations
o Most common

Ag shift
o Major changes
o Re-assortment
o Appears suddenly

47
Q

Equine Influenza: basics & clinical signs

A
  • Most common viral resp of horses
  • Relatively stable w/ some drift
  • REPORTABLE
  • Localized infections (upper & lower)
  • any age but most common in young horses that are co-mingled
Clinical signs
•	High fever
•	Depression, anorexia 

•	Nasal discharge
•	Cough - dry, harsh, non-productive 

•	resolve in 2-3 weeks
48
Q

Equine Influenza: pathogenesis, transmission, diagnosis, prevention

A

Pathogenesis
• Replication in U & L resp tract
• Replication = cell death, mucosal damage, ulceration
• Inflammation due to IFN
• Damage to mucociliary = secondary bacterial pneumonia
• Rare systemic signs

Transmission
• highly contagious via aerosols 

• Shedding prior to signs & additional 4-5 days 

• poor ventilation, high humidity, crowding 


Diagnosis
• Nasal swabs for culture PCR
• ELISA to detect viral antigen
• Serology

Prevention
• Isolation
• Vaccination: killed, modifies live, canarypox vectored

49
Q

Avian Influenza Basics; LPAI Vs HPAI

A
  • Infects wild birds & poultry species (most often subclinical)
  • Replicates in/sheds from both respiratory and enteric tracts
  • There is a systemic form of AIV infection (HPAI)

Agent
• Avian influenza virus type A

• Variety of H and N types seen

Low pathogenicity avian influenza (LPAI)
o strains most common in domestic birds (poultry)

Highly virulent (pathogenic) avian influenza (HPAI)
o uncommon
o very high morbidity and mortality rates 

o systemic spread ONLY in birds due to change in fusion proteins

50
Q

Pathogenesis & Symptoms of Low Pathogenicity Avian Influenza (LPAI)

A

Pathogenesis
• cell-to-cell spread, lytic infection of epithelial cells
• secondary bacterial infections
• can mutate & spread systemically

Symptoms
• Localized infection of respiratory and enteric tracts
• coughing, sneezing, rales, lacrimation, sinusitis
• diarrhea can occur w/o respiratory signs
• Drop in egg/meat production

51
Q

Emergence of High Pathogenicity Avian Influenza (HPAI)

A
  • LPAI infects chickens
  • Mutates in chicken
  • Potential for severe zoonotic disease in humans, but NOT systemic disease
52
Q

High Pathogenicity Avian Influenza (HPAI): symptoms & character

A
Symptoms
o	Vasculitis & lymphoid necrosis
o	Depression, lethargy, huddling
o	Cyanosis of comb & waddle or infarction
o	Edema of face
o	Hemorrhage of brain & mucosal surfaces

Character of HPAI
o Seen only with H5 and H7 subtypes 

o Causes severe systemic infections 

o short disease course = high mortality

53
Q

High Pathogenicity Avian Influenza (HPAI): Diagnosis & Control

A

Diagnosis
o History of rapidly spreading respiratory disease
o PCR viral RNA 
(choanal or cloacal swab)
o ELISA for viral antigen 

(choanal or cloacal swab)
o Serology 


Control
o	Biosecurity 
o	Surveillance 
o	Depopulation 
o	Disinfection 
o	No vaccines & no antivirals!
54
Q

Canine Influenza: two HN combos, mild form vs severe

A

H3N8
• Described in 2004 in greyhounds
• Mutation from equine

H3N2
• Described in 2008 from dogs in Asia
• Avian origin
• Able to affect cats but may be mild

Mild Form
• Cough (dry, non-productive)

• 10-21days

• Nasal discharge, Fever, lethargy, anorexia

Severe Form (uncommon)
•	High fever, pneumonia, increased resp, consolidation of lung lobes
55
Q

Canine Influenza: Transmission, diagnosis, treatment, prevention

A

Transmission
• Highly contagious
• Aerosols, respiratory secretions, Fomites
• Incubation usually 2-5 days
• Peak virus shedding 3-4 dpi but can shed virus for 7-10

Diagnosis
•	Nasal or pharyngeal swab 

•	RT-PCR to detect viral RNA 

•	Virus isolation 

•	Immunoassays to detect virus antigen 

•	Serology (later stage of illness) 


Treatment
• Supportive
• Self-limiting, recovery in 2-3 weeks 


Prevention
• Isolation
• Disinfection

Vx
• 2 doses, 2-3 weeks apart; then annual dose

56
Q

Paramyxoviruses

A

o Enveloped, (-) RNA (non-segmented) genomes
o Many can induce syncytia
o Cytoplasmic & nuclear inclusions

57
Q

Morbillivirus

A
  • Classic systemic infections, multi-organ disease

  • Major target organs include respiratory, enteric, CNS “pneumo-encephalitis”
  • Canine distemper
  • Newcastle Disease
58
Q

Canine Distemper Viral Ligand & Receptor

A

• Several co-circulating CDV genotypes: differ in virulence

Viral Ligand:
o H (hemagglutinin) protein
o immunosuppression and reduced Ag presentation

Receptor:
o CD150
o Expressed on lymphocytes, macrophages and dendritic cells

59
Q

Canine Distemper: Acute & Chronic Clinical signs & transmission (viral shedding).

A

Clinical Presentation
o Systemic infection- respiratory, GI, CNS 

o ~ 50% of cases subclinical to mild 


o Acute
• Resp & GI signs
• Neuro disease

o Chronic
• Later onset neuro signs
• Epithelial tissue may be affected

Transmission
o Direct contact, droplet, aerosol
o Virus is shed: in oro-nasal discharge
o Viral shedding: 7 days prior to clinical signs but Does NOT occur with chronic CNS disease
o Contact w/ recently infected (subclinical or diseased) animals maintains virus in population

60
Q

Canine Distemper Pathogenesis

A

o Entry via aerosols into upper respiratory tract ->
o Replication in phagocytic cells of tonsils and trachea ->
o Replication in dendritic cells, monocytes, lymphocytes of regional lymph nodes ->
o Primary viremia = 1st fever, may be missed clinically ->
o Replication/amplification
in central lymphoid tissues ->
o Secondary viremia = 2nd fever, clinically significant and often this one is noticed ->
o Recovery if vaccinated
o If not vaccinated
o Seeding of epithelium of gut, skin, lung ->
o recovery & potential old dog encephalitis OR
o acute encephalitis OR
o severe catarrhal distemper

61
Q

Canine Distemper: Diagnosis & Control

A

Diagnosis
o clinical signs, history
o Inclusions in blood cells during viremia
o culture IFA & RT-PCR (nasal & oropharyngeal swabs or epithelial samples)
o Rapid Ag tests
o Serology for Ab

Control
o vx
o occurs in unvaccinated animals & often coincides with loss of maternal Ab (~3-4 months of age)
o MLV should not be used for non-canid species
o Killed vaccines – only in dogs
o Canarypox-vectored H and F proteins are effective and safe 
for other animals

62
Q

Symptoms of Acute Distemper to

Chronic; lesions associated w/ chronic

A
Acute 
o	Fever - biphasic 

o	Rhinitis/nasal discharge 
o	Conjunctivitis 

o	Bronchitis, catarrhal pneumonia, secondary infections 

o	Gastroenteritis with vomiting and diarrhea 

o	Anorexia, depression 

o	May cause Infection of brain 


Chronic
o CNS disease usually follows acute signs by 1-3 weeks 

o overwhelming infections and/or inadequate immune responses

Presentation of lesions due to epithelial cell infection: 

o Hyperkeratosis of foot pads
o Hypoplasia of pre-eruption tooth enamal

63
Q

Pathogenesis of Distemper CNS Disease

A

Sub-acute to Chronic encephalitis
• Reduced expression of CDV antigen in CNS
• autoimmune -> Immune-mediated demyelination
• Permanent CNS impairment

Old dog encephalitis - seen years later
• Rare, chronic slow progressive

64
Q

Newcastle Disease

A
  • distemper in birds
  • Avian paramyxovirus serotype 1
  • Has virulent and low virulent form

Clinical signs
o apathy, depression, lack of movement and appetite, reduced egg production, green or watery stool, respiratory difficulty, and conjunctivitis
o Viscerotropic: internal and external hemorrhages and swelling of the head and neck
o Neurotropic: partial wing paralysis, involuntary muscle tremors, and stiff or twisted head or neck

65
Q

Basics & Lifecycle of Retroviruses

A
  • Enveloped
  • Diploid (+) RNA genome
  • Not all are oncogenic but all have potential to be

Life cycle
o Attaches to receptor or hematopoietic cell ->
o Reverse transcription of RNA -> DNA
o DNA integrated into host DNA by integrase = provirus
o Cellular polymerase makes more RNA ->
o Viral proteins produced

66
Q

Transformation by retroviruses relies on…

A

o Error prone Reverse transcription of (+) ssRNA into dsDNA
o Integration of dsDNA into host cell chromosome 

o Transcriptional regulatory sequences such as the promoter in the viral LTR

67
Q

Feline Immunodeficiency Virus (FIV); what cells does it affect, mode of proliferation

A
  • non-oncogenic lentivirus
  • infects lymphocytes
  • higher incidence of lymphoma in infected cats
  • Cis-insertional = uncontrolled cellular proliferation
68
Q

Avian Leukosis/sarcoma virus: endogenous V exogenous & Transmission

A

• Alpharetrovirus

Endongenous
• Present in genoma of all chickens
• Rarely pathogenic

Exogenous
•	Transmitted between naïve birds

•	Causes disease when associated w/ tumor development 
•	Transmission
•	Horizontal or vertical
69
Q

Clinical Syndrome of replication competent Avian Leukosis/sarcoma virus; adult vs congenital

A

Adult or young birds (horizontal)
o Transient viremia, neutralizing ab
o Leukemia rare

Congenitally infected or infected during first few days
o Persistent infection due to immune tolerance

o Large amount of infectious virus shed in saliva and feces
o Tumor development: Usually lymphoid leukosis
o Most common form seen in chickens ~14-30 wks of age

70
Q

Tumor development in Avian Leukosis/sarcoma virus

A

Lymphoid tumors
o most common
o Cis-insertional activation adjacent to cellular proto-oncogene i
o replication-competent virus

Mesenchymal tumors
o acquired proto-oncogene & transduction
o replication defective or competent virus 


Myeloid/Erythroid tumors
o acquired proto-oncogene and transduction
o replication defective virus

71
Q

Basics of replication defective Avian Leukosis/sarcoma virus

A

• Rapidly transforming & rarely transmitted from bird to bird 

o Arise in an individual bird 

o Lack full viral genes for replication
o MAY have acquired a cellular proto-oncogene (v-onc)
o Replication requires helper virus

72
Q

Diagnosis of Avian Leukosis/sarcoma virus

A
  • Necropsy lesions usually adequate 

  • Distinguished from Marek’s 
which has T-lymphocytes
  • Histopathology - homogeneous population of B-lymphocytes 

73
Q

Incidence of Avian Leukosis/sarcoma virus

A
  • Varies dramatically by country
  • rare in commercial poultry
  • common in Backyard flocks
74
Q

Control of Avian Leukosis/sarcoma virus

A

Eradication:
o Most important in primary breeding flocks and egg-laying flocks for 
vaccine production 

o Expensive 


Genetic resistance:
o Breed chickens which resist infection (very common)
o genetically resistant by changing confirmation of receptors

Management: 

o “All-in-all-out” is standard practice
o Hygiene!!

Vaccines:
o Inactivated/attenuated
o limited success

75
Q

Transducing Retroviruses

A

Acquisition & transduction of cellular genes

  • During replication, cellular gene is inserted into the retrovirus genome ->
  • genes no longer under the control of cell 
->
  • now under control of virus promoter transcription ->
  • now a viral oncogene (v-onc) 
->
  • v-onc can be transferred from one cell to another by the virus = transduction
76
Q

Avian Leukosis/Sarcoma Virus Replication Competent V defective: able to produce virons? mechanism of transformation? ocogene? tumor type? transmissbale btwn birds?

A

Able to produce infectious virions
• Competent – yes
• Defective – no

Mechanism of transformation
• Competent - Cis-insertional activation
• Defective - help from competent thru acquisition of cellular oncogene & transduction

Possesses oncogene
• Competent - no
• Defective - Yes (sarcoma)

Tumor type
• Competent -lymphoma
• Defective - sarcoma

Transmissible btwn birds
• Competent - yes
• Defective - no

77
Q

JSRV & ENTV Basics

A
  • betaretroviruses
  • JSRV - sheep
  • ENTV- 1 affects sheep, 2 affects goats
  • exogenous & endogenous types
  • Respiratory – progressive dyspnea, coughing, anorexia, nasal discharge
  • JSRV -> pulmonary epithelial cell tumor (adenocarcinoma)
  • ENTV -> nasal epithelial cell tumor (adenocarcinoma)
  • Exogenous, oncogenic retroviruses 

  • have envelope protein that acts as oncoprotein = activation of signal transduction
78
Q

JSRV & ENTV Transmission & Time to Dz

A

Transmission:
o Horizontal, close contact, aerosolized respiratory fluid

Time to disease
o prolonged incubation period = 1-3 years (affected animals usually >2 years old)
• Not all infected animals develop tumors (~30%)

79
Q

JSRV & ENTV Diagnosis & Prevention/Control

A

Diagnosis
• Clinical signs + pathology (adenocarcinoma)
• PCR - peripheral blood leukocytes, lymph node, tumor
• serology of no help

Prevention/Control
• no vaccines
• Removal of infected animals from herd

80
Q

Bovine Leukemia Virus (BLV) Basics & Character

A
  • deltaretrovirus
  • Exogenous
  • Uses trans-cellular activation
  • chronic disease evolving over 1-8 yrs
  • Most infected animals = seropositive but no clinical signs 

  • Persistent lymphocytosis in ~30% (no clinical disease) 

  • 1 - 5% of cattle develop tumors 
(B cell lymphoma)
81
Q

Bovine Leukemia Virus (BLV) Transmission

A

Horizontal
o Transfer of blood/infected lymphocytes
o Ex: Rectal palpation, Dehorning, Mechanical vector

Vertical & congenital transmission
o <10% calves virus positive at birth 

o Infected milk/colostrum to calves (congenital)

82
Q

Bovine Leukemia Virus (BLV) Diagnosis & Control

A

Diagnosis
• High incidence (1-5%) of multicentric B-lymphoma 

• Serology tests or milk ELISA 

• Agar gel immunodiffusion (AGID)

Control
• Periodic testing and elimination of positives
• VX not used for control

83
Q

Feline Leukemia Virus Basics

A
  • important causes of morbidity/mortality in cats 

  • Cause a wide spectrum of clinical manifestations - Malignancies, immunosuppression, anemia 

  • Predominantly domestic cats, but also non-domesticated big wild cats
  • Endogenous (enFeLV) or Exogenous
84
Q

Exogenous Feline Leukemia Virus; replication competent or defective, how to test, subtypes

A

FeSV
o Replication defective

FeLV
o Replication competent
o SNAP test detects core capsid protein which is in ALL subtypes
o Subtypes A, B, C, T based on genetic & Ag differences in the SU surface envelope protein
o FeLV-A is contagious and horizontally transmitted 


85
Q

Subgroups of FeLV

A
  • Virulence of B and C higher than A
  • B mainly associated with neoplasia
  • C is rare = non-regenerative anemia
  • T associated w/ immune deficiency (T lymph)
86
Q

Transmission of FeLV

A
  • via saliva
  • Virus attaches to receptors on tonsillar monocytes, macrophages, lymphocytes -> systemic spread
  • Also transmitted in milk, or in utero
  • Kittens (<16 weeks of age) are more susceptible than adults to developing progressive infections
87
Q

3 Pathogenesis of FeLV

A

Transient viremia
• replication in thymus, lymph nodes, salivary glands

Persistent viremia (progessor)
• Colonization of bone marrow ->
• Spread to epithelial cells of salivary glands, respiratory and intestinal tracts, pancreas ->
• FeLV-related disease results from cytopathic or transformative effects of virus

Latent infection (regressor)
• Virus persists in lymph nodes and bone marrow 

• Little to no viral gene expression

88
Q

Diagnosis of FeLV

A
  • Capsid Ag in blood detected by Ag ELISA (good for progressor & viremic cats)
  • Viral nucleic acid detection by PCR (good for latent infections)
  • test w/ Ag ELISA ->
  • if (-) test w/ PCR ->
  • if (-) = true (-)
  • if (+) = regressor
  • test w/ Ag ELISA ->
  • if (+) retest w/ ELISA ->
  • if (-) = regressor (test w/ PCR)
  • if (+) = progressor
89
Q

2 Basic Outcomes of FeLV infection

A

• Determined by immune response, age, concurrent dz, dose of virus

Regressive infection
•	70% of infected cats 
•	Cats develop effective immune response and curtail virus replication 
•	Transient viremia
•	Can be reactivated 
Progressive infection 
•	~30% 
•	Failure of immune response to contain virus 
•	Persistent viremia
•	Develop fatal dz
90
Q

FeLV Related Disorders

A

Immunosuppression (most common)
• Increased incidence of concurrent/opportunistic infections

Bone marrow suppression and disorders
• Usually nonregenerative and normochomic anemia

immune-mediated disease
• glomerulonephritis, polyarthritis, vasculitis
• Neurological disease

Neoplasia
• Lymphoma, lymphoid and myeloid leukemia
• Insertional activation near myc

91
Q

FeLV Prognosis & Prevention

A

Prognosis
• Progressively infected cats have 50-80% decreased survival rate
• 2.4 year median survival time

Prevention
• Management
 thru testing, good hygiene, single cat households
• Vaccination

92
Q

Lentivirus Basics; 2 effects

A

o Genetically complex retroviruses
o Non-oncogenic

o High mutation rate (RT enzyme)
o Persistent, lifelong infections
o HIV-1 is a prototypical lentivirus
o if affects monocyte/macrophages & lymphocytes = immunsuppressive
o If it affects only monocyte/macrophages = chronic systemic inflammation

93
Q

Pathogenesis of Lentiviruses; immunodeficiency subgroup Vs non-immunodefficiency

A
  • Systemic infections involving immune cells 

  • All viruses initially replicate in monocyte-macrophage 


Immunodeficiency disorder subgroup (FIV, SIV, HIV)
• Initial replication in mononuclear phagocyte system
• then becomes lymphotropic with destruction of CD4+ T lymphocytes
• Clinical dz from opportunistic infections and neoplasia

Non-immune deficiency/chronic inflammatory viruses (EIAV, OPPV, CAEV)
• clinical dz result of immune-mediated damage by Inflammation/cytokine or Virus-Ab complex

94
Q

FIV Basics

A
  • lentivirus
  • Different subtypes based on env sequence
  • Infects wild felids as well
  • life-long infection
  • can be subclinical
95
Q

Transmission of FIV

A

Horizontal
o Mainly bite/fight wounds
o Social grooming not source of transmission
o Virus present in semen, transmission?

Vertical
o In utero – uncommon,
o Colostrum/milk

96
Q

Phases of FIV

A

Acute phase
o 1-3months post infection

Chronic asymptomatic phase
o 3 mo - maybe forever
o progressive immune dysfunction
o no noticeable symptoms

Terminal / FAIDS
o clinical signs, Dz, death

97
Q

Pathogenesis of FIV

A
  • infection of monocytes/macrophages, lymphocytes- >
  • Viremia
->
  • Dissemination to CNS/lymphoid organs ->
  • Progressive immune dysfunction
  • Can also result in CNS dz
98
Q

Clinical Dz associated w/ FIV

A
  • Acute stage - lymphadenopathy, leukopenia, fever, depression, weight loss
  • Neoplasia from immune suppression, or insertional activation
  • Opportunistic infections

  • Periodontal disease, gingivitis, stomatitis

  • Chronic URT, GI, urinary tract infections/disease, CNS
  • Weight loss
  • Often no Dz!
99
Q

Diagnosis / Prevention of FIV

A
  • ELISA/SNAP, WB to detect Ab to FIV
  • (+) test = infected, Vx (not used), false (+), maternal Abs
  • Vx: not recommended
100
Q

Equine Infectious Anemia Basics, 3 Versions

A
  • lentivirus
  • Reportable Dz
  • Lifelong persistent infection
  • Infects monocytes/macrophages
 -> inflammation

o Acute: High levels of virus replication, may result in death in 1-4 weeks post-infection
o Chronic: Recurrent cycles of fever, viremia, fever, thrombocytopenia, anemia, etc.
o Inapparent: Seropositive, no clinical signs

101
Q

Equine Infectious Anemia Pathogenesis

A
  • Infection of blood monocytes >
  • monocytes disseminate to tissues throughout >
  • differentiation to macrophages >
  • activation of viral replication >
  • pro-inflammatory cytokine production by macrophages >
  • inflammation = clinical disease
102
Q

Equine Infectious Anemia Clinical Signs & Evasion of Immunity

A

Undulating 1-2 week cycles
• fever, anemia, thrombocytopenia -> petechial, icterus
• Horse often develop ability to control cycles

Chronic
• Vasculitis, glomerulonephritis
• Death from anemia and wasting if cycling is frequent

Immune Evasion
• Ag variation of viral proteins - Env 

• Periodic escape of virus from neutralizing Ab and CTL 

• Escape mutants break through = continued cycling 


103
Q

Equine Infectious Anemia Transmission, Diagnosis, & Prevention

A

Transmission
• Biting flies transfer blood from one horse to another

Diagnosis / prevention
• Coggins test confirm with ELISA
• Immediate quarantine and testing of all animals within 200 yards
• Infected horses euthanized or quarantined and monitored for life

• Positive horses cannot cross state lines

• No vaccine

104
Q

Coggins Test

A
  • Test for equine infectious anemia
  • Detects Ab against viral protein p26 

  • Required for transport across state lines 

  • infected animals may have false (-) result -> 3 wks-3mos to mount an Ab response
105
Q

Small Ruminant Lentiviruses

A
  • Caprine Arthritis Encephalitis Virus (CAEV) & Ovine Progressive Pneumonia Virus (OPPV)
  • Persistent life-long infection
  • Chronic inflammatory diseases w/ long incubation period
  • affects Joints, Brain, Lungs
106
Q

Pathogenesis of Small Ruminant Lentiviruses

A
  • Transmitted thru colostrum/milk ->
  • Infects monocytes/macrophages ->
  • Inflammation in organs
107
Q

Caprine Arthritis Encephalitis Virus (CAEV) Vs Ovine Progressive Pneumonia Virus (OPPV); diagnosis & prevention

A

CAEV
• Adults = arthritis in joints
• Kids – neuro dz = ascending paralysis (uncommon)

OPPV
• Lungs – progressive interstitial pneumonia (adults)
• Brain – hind leg weakness, paresis, etc (adults)

Diagnosis:
o serology ELISA for Ab

Prevention/Control
o Do not allow kids to drink milk